High rate of early cancer recurrence following direct-acting antiviral treatment for hep C virus
A new study fast-tracked for publication today in the Journal of Hepatology has shown that patients with a prior history of hepatocellular carcinoma (HCC) and who have been treated with direct-acting antivirals (DAAs) for ...
Apr 14, 2016
0
0